1.Pharmacokinetics Experiment about Huanglianjiedu Decoction and Application of Data Mining
Zhilei QIAN ; Mingfei ZENG ; Huaxu ZHU
Journal of Zhejiang Chinese Medical University 2006;0(04):-
[Objective] To find the method of pharmacokinetics experiment about Huanglianjiedu Decoction.[Methods] According to references about pharmacokinetics experiments on Huanglianjiedu Decoction,the article summarized the achievements in quantitative analysis,the influence of distill techniques and pharmacokinetics on indict components in Huanglianjiedu Decoction.This article attached importance to applying the technologies of PK-PD modeling and Data Mining in research of Chinese traditional medicine compound.[Conclusion] The pharmacokinetics study on Huanglianjiedu Decoction is just in the first step; thereby further studies will be taken on this decoction in order to reveal the active fractions and effect mechanism.
2.Practice and Exploration of Clinical Pharmacy of Traditional Chinese and Western Integrative Medicine in a Special Hospital
Zhilei QIAN ; Lei LU ; Liang ZHANG ; Qiuyun ZHOU ; Hongzi DING ; Jie WANG
China Pharmacist 2015;(11):1901-1903
Objective: To summarize the experience of clinical pharmacy of traditional Chinese medicine in a special hospital. Methods: Combining the work of clinical pharmacists in the hospital, the service content of clinical pharmacy of traditional Chinese medicine in the special hospital was described and the improvement methods were explored. Results:The pharmaceutical care of clini-cal pharmacy of traditional Chinese medicine could improve safe and rational use of drugs. Conclusion: Pharmacists should enhance the study of pharmacy and traditional Chinese medicine to improve the pharmaceutical care of clinical pharmacy of traditional Chinese medicine.
3.Thoughts on fund compensation of adverse events following immunization in China
Ting SU ; Zhilei ZHONG ; Dan YOU ; Litao RUAN ; Shengran YANG ; Qian LI ; Qiuyu CHEN ; Zexu YU ; Cheng LI
Shanghai Journal of Preventive Medicine 2022;34(4):382-387
After the promulgation and implementation of the Vaccine Administration Law of the People’s Republic of China, the compensation of suspected adverse reactions in China is to be reformed and innovated. There have been attempts at compensation through government finance and insurance, but there has been no precedent for a fund of vaccine-related compensation in China, which means that this could be a new method of solving disputes of compensation for vaccine-related incidences and enhancing public confidence in vaccination. It is suggested that under the current system, we can select a province as a pilot to explore the fund compensation mechanism. The fund comes from special financial allocation, special taxation of vaccine enterprises, fund investment income, charitable donation and other channels. Through a special fund management organization, the independent identification and compensation process can be realized, so as to shorten the current compensation procedure, improve the amount of compensation, ultimately protect the interests of all parties, and promote the steady development of vaccination.